David Rosenbaum - Nov 20, 2023 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Stock symbol
ARDX
Transactions as of
Nov 20, 2023
Transactions value $
-$16,432
Form type
4
Date filed
11/22/2023, 05:21 PM
Previous filing
Oct 12, 2023
Next filing
Dec 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Sale -$12.4K -2.84K -0.78% $4.36 363K Nov 20, 2023 Direct F1
transaction ARDX Common Stock Sale -$4.07K -932 -0.82% $4.36 113K Nov 20, 2023 By Wife F1, F2
holding ARDX Common Stock 77.6K Nov 20, 2023 Family Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
F2 The shares are directly held by the Reporting Person's wife.
F3 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.